TABLE 1.
Yeast strains and plasmids used in this study
Strain or plasmid | Genotype or descriptiona | Reference or source |
---|---|---|
Strains | ||
FY1353 | MATα his3Δ200 ura3-52 leu2Δ1 lys2-173R2 | 39 |
RH2561 | Same as FY1353 but with plasmid pRS303 (HIS3) | This work |
FY1354 | MATα his3Δ200 ura3-52 leu2Δ1 lys2-173R2 gcn5Δ::HIS3 | 39 |
FY1360 | MATa his3Δ200 ura3-52 leu2Δ1 lys2-173R2 snf2Δ::LEU2 | 39 |
RH2563 | Same as FY1360 but with plasmid pRS303 (HIS3) | This work |
FY1352 | MATa his3Δ200 ura3-52 leu2Δ1 lys2-173R2 gcn5Δ::HIS3 snf2Δ::LEU2 | 39 |
RH1381 | MATa ura3-52 aro3-2 gcn4-101 | 37 |
RH1616 | MATa ura3-52 aro3-2 his7-lacZ gcn4-101 | 37 |
RH2029 | MATa ura3-52, gcn4-101 bas1-2 bas2-2 | 45 |
RH2569 | MATa ura3-52 aro3-2 his7-lacZ gcn5Δ::loxP | This work |
RH2570 | MATa ura3-52 aro3-2 his7-lacZ gcn4-101 gcn5Δ::loxP | This work |
RH1619 | MATa ura3-52 aro3-2 his7(mut GCRE1)-lacZ gcn4-101 | 37 |
RH1622 | MATa ura3-52 aro3-2 his7(mut GCRE2)-lacZ gcn4-101 | 37 |
RH1830 | MATa ura3-52 aro3-2 his7(mut ABS)-lacZ gcn4-101 | 36 |
Plasmids | ||
pBluescript II SK(+) | Commercial cloning vector with polylinker; lacZ | Stratagene |
pUG6 | loxP-kanMX-loxP module with Kanr marker flanked by TEF2 promoter and terminator, Ampr | 17 |
pME1768 | loxP-kanMX-loxP module from pUG6 in pBluescript II SK(+) | |
pME2034 | 774-bp GCN5 3′ fragment in pBluescript II SK(+) | This work |
pME2035 | 862-bp GCN5 5′ fragment in pBluescript II SK(+) | This work |
pME2036 | 1.6-kb kanMX fragment from pME1768 in between GCN5 5′ and 3′ fragment | This work |
pSH47 | cre recombinase expression vector | 17 |
pRS303 | Yeast integrative vector; lacZ HIS3 | 35 |
pCB159 | pGAL-BAS1 (SpeI-MluI 3.6-kb fragment) in B656 backbone | 44 |
p238 | YCp50 carrying a GCN4 allele with mutated uORFsb | 27 |
Kanr, kanamycin resistance; Ampr, ampicillin resistance.
uORFs, upstream open reading frames.